Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:33:19 EDT Sat 18 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:PRTC
- PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS -
Website unknown - click to update
16:33:19 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
PRTC
- Q
0.2
11.44
·
29.52
9.2
28.6811
-0.2
0.1
3
7
34.00 17.08
16:00:01
May 09
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - All 7 today
More trades...
Time ET
Ex
Price
Change
Volume
16:00:01
Q
27.90
-0.7811
2
15:47:27
Q
27.96
-0.7211
6
13:38:09
Q
25.79
-2.8911
2
13:31:16
Q
29.52
0.8389
1
10:10:03
Q
28.33
-0.3511
64
09:30:00
Q
28.66
-0.0211
1
09:30:00
Q
28.66
-0.0211
1
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-05-09 07:05
U:PRTC
News Release
200
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
2024-05-07 07:05
U:PRTC
News Release
200
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
2024-04-25 05:22
U:PRTC
News Release
200
PureTech Announces Annual Results for Year Ended December 31, 2023
2024-04-18 02:00
U:PRTC
News Release
200
PureTech Health: Notice of Results
2024-04-16 07:00
U:PRTC
News Release
200
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
2024-04-11 07:00
U:PRTC
News Release
200
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
2024-04-09 02:00
U:PRTC
News Release
200
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
2024-03-19 03:00
U:PRTC
News Release
200
PureTech Proposes $100 Million Capital Return
2024-03-18 09:52
U:PRTC
News Release
200
Bristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion
2024-03-13 07:00
U:PRTC
News Release
200
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
2024-02-27 07:00
U:PRTC
News Release
200
PureTech to Present at Two Upcoming Investor Conferences
2024-02-27 02:00
U:PRTC
News Release
200
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx (TM) for Pediatric ADHD Patients in Japan
2024-01-03 07:00
U:PRTC
News Release
200
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
2023-12-22 09:13
U:PRTC
News Release
200
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
2023-12-20 02:00
U:PRTC
News Release
200
PureTech Year End Update and Outlook for 2024
2023-12-07 06:00
U:PRTC
News Release
200
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
2023-11-29 10:17
U:PRTC
News Release
200
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
2023-11-17 02:00
U:PRTC
News Release
200
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
2023-11-14 02:00
U:PRTC
News Release
200
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
2023-10-17 02:00
U:PRTC
News Release
200
PureTech to Present at Two Upcoming Investor Conferences